We are a national high-tech enterprise focusing on the field of animal health for more than 10 years, headquartered in Tianjin, China. Over the years, we have been committed to relying on continuous technological innovation, constantly accelerating the development and application of new drugs, including the research and development of key intermediates, APIs, preparations, GMP production and sales, adhering to the business philosophy of "survival by quality, development by reputation", and won the trust and support of distributors and consumers.
In 2021, the company further focused on core therapeutic areas such as pet skin diseases, infectious diseases, cardiovascular diseases, endocrine and metabolic diseases, and neoplastic diseases, and was committed to providing breakthrough and reliable innovative drugs for the pet market. The company has established standardized physical and chemical analysis laboratories, microbiology laboratories, innovative drug research and development laboratories and GMP preparation production workshops, and strictly manages the whole process of R&D and production in strict accordance with GMP, ISO9001, FDA and other relevant quality management systems.
